Jason Aryeh has served as Ligand's Director since October, 2006. Mr. Aryeh is
Founder and General Partner of JALAA Equities, LLP, a private hedge
fund focused on the Biotechnology and Specialty Pharmaceutical sector.
Mr. Aryeh actively serves as both a Special Advisor to the Cystic
Fibrosis Foundation (CFF) for Drug Discovery, and as Honorary Chairman
of the New Mexico Chapter of the CFF. Mr. Aryeh received his AB with
honors in economics from Colgate University.